Large-scale randomised controlled trials and post-marketing surveillance data have not identified ED as a common or characteristic adverse effect of these medications
Product Specifications Quantity: 10 mg per vial Form: Lyophilized powder Storage (unreconstituted): Cool, dry location Storage (reconstituted): Refrigerate at 2C-8C Research Use Only This product is intended exclusively for laboratory and scientific research
In certain clinical trials, when compared to a placebo, patients who used Wegovy lost about 15% of their starting body weight in the first 1 to 1.5 years, Zepbound medication users lost 16%, Foundayo medication users lost 12.4%, and Saxenda users lost 5%
[18] A 2019 study used liver function tests (serum, total bilirubin, alkaline phosphatase, alanine aminotransferase, gamma-glutamyl transferase, lactate dehydrogenase, and aspartate aminotransferase) and clinical observation of any adverse events to evaluate the safety of IV infusion of NAD+ in a cohort of healthy male participants (n=11